Wells Fargo & Company Galapagos Nv Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$32.2 - $42.44 $13,910 - $18,334	432 New	432 $13,000
Q3 2023 Nov 13, 2023	SELL	$34.17 - $42.98 $341 - $429	-10 Reduced 4.95%	192 $6,000
Q2 2023 Aug 15, 2023	BUY	$37.4 - $44.52 $7,554 - $8,993	202 New	202 $8,000
Q4 2022 Feb 13, 2023	SELL	$37.44 - $46.51 $330,145 - $410,125	-8,818 Reduced 96.22%	346 $15,000
Q3 2022 Nov 14, 2022	SELL	$42.27 - $57.6 $14,625 - $19,929	-346 Reduced 3.64%	9,164 $391,000
Q2 2022 Aug 12, 2022	BUY	$52.3 - $71.59 $28,974 - $39,660	554 Added 6.19%	9,510 $531,000
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $452,693 - $604,238	8,821 Added 6534.07%	8,956 $556,000
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $10,299 - $12,509	-219 Reduced 61.86%	135 $8,000
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $15,911 - $21,411	305 Added 622.45%	354 $19,000
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $4.38 Million - $5.3 Million	-63,565 Reduced 99.92%	49 $3,000
Q1 2021 May 13, 2021	BUY	$76.15 - $111.94 $502,285 - $738,356	6,596 Added 11.57%	63,614 $4.9 Million
Q4 2020 Feb 09, 2021	BUY	$96.85 - $148.25 $802,595 - $1.23 Million	8,287 Added 17.01%	57,018 $5.64 Million
Q3 2020 Nov 05, 2020	BUY	$122.47 - $213.56 $460,977 - $803,839	3,764 Added 8.37%	48,731 $6.92 Million
Q2 2020 Aug 13, 2020	BUY	$185.52 - $231.25 $314,456 - $391,968	1,695 Added 3.92%	44,967 $8.87 Million
Q1 2020 May 14, 2020	BUY	$143.0 - $274.03 $6.19 Million - $11.9 Million	43,272 New	43,272 $8.48 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.